ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1350

Multi-Targeted Loop-Mediated Isothermal Amplification for Rapid Diagnosis of Osteoarticular Tuberculosis in 60 Minutes: Experience from North India

Kusum Sharma1, Aman Sharma2 and Mandeep Dhillon3, 1Department of Medical Microbiology,, PGIMER,, Chandigarh, India, 2Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India, 3Department of Ortho[aedics,, PGIMER,, Chandigarh, India

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Tuberculosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Infection-related Rheumatic Disease: Poster Session

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Loop-mediated Isothermal Amplification (LAMP) is a promising nucleic-acid amplification assay. Prompt and accurate diagnosis of Osteoarticular tuberculosis (OATB) is required for early treatment, better patient outcomes and to prevent further joint destruction.The objective of the present study was to evaluate the LAMP test using IS6110 and MPB64 targets specific for Mycobacterium tuberculosis complex for rapid diagnosis of OATB. Comparison of results of IS6110 LAMP, MPB64 LAMP test with IS6110 PCR, culture and AFB smear

Methods:

LAMP  assay using six pairs of primers (each  for IS6110 and MPB64 ) specific for Mycobacterium tuberculosis were performed on synovial fluid/pus samples of 90 patients(10 confirmed,  80 suspected ) of  OATB  and 30 non tuberculosis controls subjects.

Results:

Overall LAMP test (using any of two targets) had sensitivity and specificity of 100% for confirmed OATB cases. In 80 clinically diagnosed but unconfirmed OATB cases LAMP was positive in 71/80 (88.75%) cases. Senstivity of IS6110 LAMP, MPB64 LAMP and IS6110 PCR in clinically unconfirmed OATB cases was 81.75% (65/80),  86.25% (69/80) and 72.5%( 58/80) respectively.  The overall sensitivity of microscopy, culture, IS6110 PCR, IS6110LAMP, MPB64 LAMP and LAMP test ( if any of the targets were used ) were 3.33%, 11.1%, 73.33%, 83.33%, 87.77% and 90%  respectively. Specificity of all the tests were100%.There were 4 cases which were missed by IS6110 LAMP assay and 2 cases were missed by MPB64 LAMP assay.

Conclusion:

LAMP assay using two targets is promising technique for rapid diagnosis of OATB in 60 minutes.


Disclosure: K. Sharma, None; A. Sharma, None; M. Dhillon, None.

To cite this abstract in AMA style:

Sharma K, Sharma A, Dhillon M. Multi-Targeted Loop-Mediated Isothermal Amplification for Rapid Diagnosis of Osteoarticular Tuberculosis in 60 Minutes: Experience from North India [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/multi-targeted-loop-mediated-isothermal-amplification-for-rapid-diagnosis-of-osteoarticular-tuberculosis-in-60-minutes-experience-from-north-india/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/multi-targeted-loop-mediated-isothermal-amplification-for-rapid-diagnosis-of-osteoarticular-tuberculosis-in-60-minutes-experience-from-north-india/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology